As of November 2024, RespireRx Pharmaceuticals has a market cap of $1.18M. This makes RespireRx Pharmaceuticals the world's 36646th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $613.26K | 44.44% |
2023 | $424.57K | -60.87% |
2022 | $1.09M | -80.34% |
2021 | $5.52M | -59.66% |
2020 | $13.68M | -97.10% |
2019 | $471.69M | -84.62% |
2018 | $3.07B | -42.98% |
2017 | $5.38B | -59.29% |
2016 | $13.21B | -53.68% |
2015 | $28.52B | -58.76% |
2014 | $69.14B | 72.80% |
2013 | $40.01B | 0.38% |
2012 | $39.86B | -71.11% |
2011 | $137.98B | -47.67% |
2010 | $263.70B | 65.38% |
2009 | $159.44B | -81.89% |
2008 | $880.32B | 16.00% |
2007 | $758.89B | -60.40% |
2006 | $1.92T | -45.18% |
2005 | $3.50T | -15.87% |
2004 | $4.15T | 4.23% |
2003 | $3.99T | 312.70% |
2002 | $965.87B | -75.58% |
2001 | $3.96T | 68.52% |
2000 | $2.35T | 112.64% |
1999 | $1.10T | 9.76% |
1998 | $1.01T | -56.27% |
1997 | $2.30T | -59.33% |
1996 | $5.65T | -15.70% |
1995 | $6.71T | 75.00% |
1994 | $3.83T | -72.41% |
1993 | $13.89T | 11.54% |
1992 | $12.46T | -10.34% |
1991 | $13.89T | 383.33% |
1990 | $2.87T | -63.64% |
1989 | $7.91T | - |